Developmental outcomes in cerebrospinal fluid proven enteroviral meningitis in neonates > 32 weeks of gestation. (March 2016)

• Record Type: Journal Article
• Authors: Balasubramanian, Haribalakrishna; Wagh, Deepika; Rao, Shripada; Keil, Anthony D; McMichael, Judy
• Is Part Of: Journal of paediatrics and child health. Volume 52:Number 3(2016:Mar.)
• Page Start: 327
• Page End: 332
• Publication Date: 2016-03
• Subjects: enterovirus -- meningitis -- neonate -- neurodevelopment; Children -- Health and hygiene -- Periodicals; Pediatrics -- Periodicals; 618.92
• DOI: 10.1111/jpc.13083
• Languages: English
• ISSNs: 1034-4810

Abstract

Abstract : Aim: The aim of this study is to assess the short‐term and long‐term (1 year) outcomes of cerebrospinal fluid (CSF) confirmed enteroviral meningitis in neonates > 32 weeks of gestation. Methods: A retrospective audit of neonates admitted between 1 July 2002 to 30 June 2012. Results: Thirty‐three neonates were diagnosed with enteroviral meningitis based on a positive CSF enteroviral PCR. Physical growth and neurodevelopmental outcomes at 1 year corrected for prematurity were available for 24 infants. All infants were alive at 1 year. The median weight, length and head circumference at 1 year were in the 72nd, 62nd and 78th centile and were comparable with the birth parameters. The mean general quotient (GQ) was 98.5 (SD 7.1) and was not significantly different from the population mean of 100.2 ( P = 0.27). None of the infants had a GQ > 2SD below the population mean. Neurological recovery was complete in the 24 neonates assessed except one, who developed cerebral palsy, epilepsy and progressive hydrocephalus requiring ventriculoperitoneal shunt at 1 year. Conclusion: Neonatal enteroviral meningitis was associated with optimal growth and neurodevelopment in the majority of the infants at 1 year corrected for prematurity. Longer term studies are needed to better define developmental outcomes.